SCHEMBL7532023

SCHEMBL7532023

COc1ccc(-c2cn(CC(=O)O)c3cc(OC)cc(OC)c3c2=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.48
ALDH1A1 P00352 5/20 0.48
CYP3A4 P08684 4/20 0.48
KDM4E B2RXH2 3/20 0.48
HSD17B10 Q99714 3/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
PTGS2 P35354 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
TP53 P04637 2/20 0.42
MAPT P10636 2/20 0.42
THRB P10828 1/20 0.42
HPGD P15428 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
GFER P55789 1/20 0.41
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7536631 0.89 CASP3 (0.47) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7260644 0.87 EGFR (0.50) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7257558 0.86 TSPO (0.45) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7256749 0.84 ALDH1A1 (0.48) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7261259 0.84 EGFR (0.48) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7531263 0.82 PTGS2 (0.45) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7257604 0.82 ALDH1A1 (0.46) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7260717 0.82 ALDH1A1 (0.48) EGFRALDH1A1CYP3A4KDM4EHSD17B10
SCHEMBL7530216 0.81 PTGS2 (0.44) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7261248 0.80 ALDH1A1 (0.46) EGFRALDH1A1CYP3A4KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1202971-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES LABORATOIRE L. LAFON (FR) 2002-05-08 EP disclosed
WO-2002022074-A2 USE OF 2- AND 4- QUINOLONES FOR INHIBITING INTIMAL NEO-PROLIFERATION LABORATOIRE L. LAFON (FR) 2002-03-21 WO disclosed
WO-2001012607-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING 4-QUINOLONES FOR TREATING CANCERS LABORATOIRE L. LAFON (FR) 2001-02-22 WO disclosed